Search results
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 8 hours agoIn the first quarter, Wainua royalty revenues were $1 million. Wainua generated sales of $5 million...
New antibiotic based on AstraZeneca drugs kills off deadly bacteria, spares the good guys
FierceBiotech· 7 days agoA new antibiotic based on drugs developed by AstraZeneca can kill off dangerous bacteria that cause...
AstraZeneca PLC ADR TradeGate Stock Price Today | NASDAQ AZNPy Live Ticker - Investing.com
Investing.com· 1 day agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Astra's Enhertu breast cancer trial shows 'unprecedented' results
Reuters via AOL· 4 days ago(Reuters) -AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 5 days agoStudy participants had already received one hormone therapy and a type of drug called a CDK 4/6...
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 1 day agoOsimertinib, produced by AstraZeneca under the brand name Tagrisso, significantly extends the time patients live without their cancer worsening, offering the first effective ...
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Zacks via Yahoo Finance· 8 hours agoEmpaveli recorded sales of $25.6 million in the reported quarter, up 25.5% from the year-ago...
Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support...
Morningstar· 5 days agoTempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm ...
Patient’s Dark Fantasy About Aetna Lands Him in Jail
The Daily Beast via Yahoo News· 3 days agoMany Americans loathe their health insurance providers.A majority say they have severe concerns about financial hardship due to medical bills—even with...
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC NEWS· 6 days agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...